Stoke Therapeutics Inc (STOK)
12.02
+0.33
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
12.00
-0.02
(-0.17%)
After-Hours: 20:00
Stoke Therapeutics Price: 12.02 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 12.00 | 12.60 | 11.58 | 12.02 | 529277.0 |
| May 02, 2024 | 11.66 | 11.98 | 11.45 | 11.69 | 704158.0 |
| May 01, 2024 | 11.14 | 11.82 | 10.97 | 11.56 | 924333.0 |
| Apr 30, 2024 | 11.69 | 11.93 | 10.98 | 11.03 | 762834.0 |
| Apr 29, 2024 | 11.80 | 12.73 | 11.50 | 11.86 | 936133.0 |
| Apr 26, 2024 | 11.60 | 12.43 | 11.49 | 12.41 | 896225.0 |
| Apr 25, 2024 | 11.41 | 11.82 | 11.11 | 11.69 | 564531.0 |
| Apr 24, 2024 | 11.18 | 12.04 | 11.07 | 11.66 | 1.474M |
| Apr 23, 2024 | 11.24 | 11.87 | 11.07 | 11.25 | 637368.0 |
| Apr 22, 2024 | 12.00 | 12.00 | 10.90 | 11.25 | 1.290M |
| Apr 19, 2024 | 11.55 | 12.20 | 11.50 | 12.05 | 1.012M |
| Apr 18, 2024 | 11.76 | 12.27 | 11.54 | 11.65 | 1.408M |
| Apr 17, 2024 | 12.51 | 12.97 | 11.63 | 11.72 | 791129.0 |
| Apr 16, 2024 | 12.00 | 12.76 | 11.81 | 12.45 | 392387.0 |
| Apr 15, 2024 | 12.81 | 12.87 | 12.00 | 12.21 | 2.371M |
| Apr 12, 2024 | 13.35 | 13.82 | 12.54 | 12.77 | 526832.0 |
| Apr 11, 2024 | 12.88 | 13.61 | 12.41 | 13.50 | 527955.0 |
| Apr 10, 2024 | 12.31 | 13.01 | 12.20 | 12.76 | 603027.0 |
| Apr 09, 2024 | 13.00 | 13.30 | 12.18 | 12.85 | 1.771M |
| Apr 08, 2024 | 12.70 | 13.49 | 12.52 | 13.00 | 991208.0 |
| Apr 05, 2024 | 12.18 | 12.86 | 11.80 | 12.57 | 635910.0 |
| Apr 04, 2024 | 13.05 | 13.89 | 11.77 | 12.17 | 892563.0 |
| Apr 03, 2024 | 13.04 | 13.49 | 12.33 | 12.82 | 1.380M |
| Apr 02, 2024 | 13.10 | 13.11 | 12.00 | 13.08 | 2.000M |
| Apr 01, 2024 | 13.22 | 13.64 | 12.59 | 13.49 | 1.451M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.37
Minimum
Oct 27 2023
69.81
Maximum
Jan 19 2021
21.86
Average
21.77
Median
Oct 04 2019
Price Benchmarks
| NeuBase Therapeutics Inc | 0.405 |
| iBio Inc | 1.99 |
| Actinium Pharmaceuticals Inc | 8.96 |
| Lixte Biotechnology Holdings Inc | 2.89 |
| Fate Therapeutics Inc | 4.06 |
Price Related Metrics
| PS Ratio | 60.22 |
| Price to Book Value | 3.488 |
| Earnings Yield | -19.72% |
| Market Cap | 556.57M |